Documents
Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | EQ 100MG BASE/ML | 1 | DEPACON | VALPROATE SODIUM |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 1996-12-30 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2000-06-19 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 1999-12-08 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 2000-05-15 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 2000-06-20 | STANDARD |
EFFICACY; Efficacy | SUPPL | 6 | AP | 2002-01-24 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 7 | AP | 2002-06-26 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 8 | AP | 2002-08-12 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2002-12-12 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2006-01-11 | STANDARD |
LABELING; Labeling | SUPPL | 15 | AP | 2006-10-13 | STANDARD |
LABELING; Labeling | SUPPL | 16 | AP | 2011-10-07 | STANDARD |
LABELING; Labeling | SUPPL | 19 | AP | 2014-06-19 | STANDARD |
LABELING; Labeling | SUPPL | 20 | AP | 2011-10-07 | UNKNOWN |
LABELING; Labeling | SUPPL | 23 | AP | 2011-10-07 | UNKNOWN |
LABELING; Labeling | SUPPL | 25 | AP | 2013-02-27 | STANDARD |
LABELING; Labeling | SUPPL | 26 | AP | 2013-07-31 | STANDARD |
LABELING; Labeling | SUPPL | 27 | AP | 2013-06-14 | STANDARD |
LABELING; Labeling | SUPPL | 28 | AP | 2014-11-20 | STANDARD |
LABELING; Labeling | SUPPL | 29 | AP | 2015-01-07 | STANDARD |
LABELING; Labeling | SUPPL | 30 | AP | 2014-06-09 | STANDARD |
LABELING; Labeling | SUPPL | 31 | AP | 2014-08-20 | STANDARD |
LABELING; Labeling | SUPPL | 32 | AP | 2015-03-13 | STANDARD |
LABELING; Labeling | SUPPL | 33 | AP | 2015-09-23 | STANDARD |
LABELING; Labeling | SUPPL | 34 | AP | 2016-02-18 | STANDARD |
LABELING; Labeling | SUPPL | 35 | AP | 2016-11-02 | STANDARD |
LABELING; Labeling | SUPPL | 36 | AP | 2017-03-06 | STANDARD |
LABELING; Labeling | SUPPL | 37 | AP | 2017-10-05 | STANDARD |
LABELING; Labeling | SUPPL | 38 | AP | 2018-03-06 | STANDARD |
LABELING; Labeling | SUPPL | 39 | AP | 2019-02-21 | STANDARD |
LABELING; Labeling | SUPPL | 40 | AP | 2019-11-22 | STANDARD |
LABELING; Labeling | SUPPL | 41 | AP | 2020-05-19 | STANDARD |
Submissions Property Types
SUPPL | 1 | Null | 0 |
SUPPL | 3 | Null | 0 |
SUPPL | 4 | Null | 0 |
SUPPL | 5 | Null | 0 |
SUPPL | 7 | Null | 0 |
SUPPL | 8 | Null | 0 |
SUPPL | 16 | Null | 15 |
SUPPL | 19 | Null | 6 |
SUPPL | 20 | Null | 7 |
SUPPL | 23 | Null | 15 |
SUPPL | 25 | Null | 6 |
SUPPL | 26 | Null | 6 |
SUPPL | 27 | Null | 6 |
SUPPL | 28 | Null | 7 |
SUPPL | 29 | Null | 7 |
SUPPL | 30 | Null | 15 |
SUPPL | 31 | Null | 6 |
SUPPL | 32 | Null | 6 |
SUPPL | 33 | Null | 7 |
SUPPL | 34 | Null | 7 |
SUPPL | 35 | Null | 15 |
SUPPL | 36 | Null | 6 |
SUPPL | 37 | Null | 6 |
SUPPL | 38 | Null | 6 |
SUPPL | 39 | Null | 7 |
SUPPL | 40 | Null | 15 |
SUPPL | 41 | Null | 6 |
CDER Filings
ABBVIE
cder:Array
(
[0] => Array
(
[ApplNo] => 20593
[companyName] => ABBVIE
[docInserts] => ["",""]
[products] => [{"drugName":"DEPACON","activeIngredients":"VALPROATE SODIUM","strength":"EQ 100MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
[labels] => [{"actionDate":"05\/19\/2020","submission":"SUPPL-41","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/020593s041lbl.pdf\"}]","notes":""},{"actionDate":"11\/22\/2019","submission":"SUPPL-40","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020593s040lbl.pdf\"}]","notes":""},{"actionDate":"02\/21\/2019","submission":"SUPPL-39","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020593s039lbl.pdf\"}]","notes":""},{"actionDate":"03\/06\/2018","submission":"SUPPL-38","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020593s038lbl.pdf\"}]","notes":""},{"actionDate":"10\/05\/2017","submission":"SUPPL-37","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020593s037lbl.pdf\"}]","notes":""},{"actionDate":"03\/06\/2017","submission":"SUPPL-36","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020593s036lbl.pdf\"}]","notes":""},{"actionDate":"11\/02\/2016","submission":"SUPPL-35","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/020593s035lbl.pdf\"}]","notes":""},{"actionDate":"02\/18\/2016","submission":"SUPPL-34","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/020593s034lbl.pdf\"}]","notes":""},{"actionDate":"09\/23\/2015","submission":"SUPPL-33","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/020593s033lbl.pdf\"}]","notes":""},{"actionDate":"03\/13\/2015","submission":"SUPPL-32","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/020593s032lbl.pdf\"}]","notes":""},{"actionDate":"01\/07\/2015","submission":"SUPPL-29","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/020593s029lbl.pdf\"}]","notes":""},{"actionDate":"11\/20\/2014","submission":"SUPPL-28","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020593s028lbl.pdf\"}]","notes":""},{"actionDate":"08\/20\/2014","submission":"SUPPL-31","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020593s031lbl.pdf\"}]","notes":""},{"actionDate":"06\/19\/2014","submission":"SUPPL-19","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020593s019lbl.pdf\"}]","notes":""},{"actionDate":"06\/09\/2014","submission":"SUPPL-30","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/018081s060,018082s043,018723s052,019680s039,020593s030,021168s028lbl.pdf\"}]","notes":""},{"actionDate":"07\/31\/2013","submission":"SUPPL-26","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/020593s026lbl.pdf\"}]","notes":""},{"actionDate":"06\/14\/2013","submission":"SUPPL-27","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/020593s027lbl.pdf\"}]","notes":""},{"actionDate":"02\/27\/2013","submission":"SUPPL-25","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/020593s025lbl.pdf\"}]","notes":""},{"actionDate":"10\/07\/2011","submission":"SUPPL-23","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020593s016s020s023lbl.pdf\"}]","notes":""},{"actionDate":"10\/07\/2011","submission":"SUPPL-20","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020593s016s020s023lbl.pdf\"}]","notes":""},{"actionDate":"10\/07\/2011","submission":"SUPPL-16","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020593s016s020s023lbl.pdf\"}]","notes":""},{"actionDate":"10\/13\/2006","submission":"SUPPL-15","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/18081s44,18082s27,18723s33,19680s22,20593s15,21168s14lbl.pdf\"}]","notes":""},{"actionDate":"01\/11\/2006","submission":"SUPPL-11","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/018081s42,18082s26,18723s32,19680s19,20593s11,21168s9lbl.pdf\"}]","notes":""},{"actionDate":"01\/24\/2002","submission":"SUPPL-6","supplementCategories":"Efficacy-New Dosing Regimen","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2002\\\/20593s006lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"DEPACON","submission":"VALPROATE SODIUM","actionType":"EQ 100MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2020-05-19
)
)